NCT00772408View on ClinicalTrials.gov

Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Pulmonary TuberculosisGenetic Variants of HostImmune Response of Host

Trial Locations (2)

886

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung Hsien

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER

NCT00772408 - Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis | Biotech Hunter | Biotech Hunter